April 7-11, 2025

The 2nd CRISPR Medicine Conference 2025, April 7-11, Copenhagen, Denmark

Important Dates for the 2nd CRISPR Medicine Conference 2025

Before the Event:

  • July 1st 2024: Registration & abstract submissions open
  • January 3rd 2025: Early bird registration deadline
  • January 17th 2025: Abstract submission deadline
  • February 28th 2025: Oral and poster notifications & final programme available
  • March 3rd 2025: Travel grant notification
  • April 4th 2025: Registration deadline in-person event
  • April 4th 2025: Registration deadline virtual event
  • April 7th 2025: Abstract publication in the CRISPR Medicine News portal


  • Scientific Conference Virtual Event: April 7th 2025
  • Scientific Conference In-person Event: April 8th - 11th 2025, Copenhagen, Denmark
  • Startup-Investor In-person Event: April 8th 2025, Copenhagen, Denmark: "Invest in Future CRISPR Medicine | Develop Future Medicine" | B2B networking | Investors and early-phase startups


The 2nd CRISPR Medicine Conference (in-person) will take place in Copenhagen, Denmark from the 8th - 11th April 2025 (virtual event 7th April).

This event will bring the global CRISPR Medicine community to the forefront, with focus on the most critical topics in the therapeutic gene-editing field: Tools, Delivery, Safety, Functional Genomics, Standards and Regulations, Pre-clinical Research and Clinical Trials.

The Scientific Conference will include both a virtual event and an in-person event and will include talks by reputable speakers from academia and industry, as well as several workshops focused on developing useful skills for a successful career in gene editing.

New for CRISPRMED25: A unique Startup-Investor event will take place at the conference venue on Tuesday morning 9th April 2024 (before the Scientific Conference begins). Selected founders from CRISPR startups and investors will present at this event, followed by 1:1 meetings. If you are an investor or part of an early-stage startup and would like to attend this meeting and/or the Scientific Conference, please register to attend here.

You can register to attend the event and submit an abstract directly through this website. Our separate in-person and virtual poster sessions will allow any type of attendee to present and discuss their research with their peers.

Attendees who submit the top-scoring abstracts will be invited to present their work in an oral presentation and selected delegates will be interviewed by CRISPR Medicine News, which boasts an audience of over 25,000 readers per month.

Once you have registered, you will be able to explore the content and see the list of participants.

Meet the confirmed CRISPRMED25 attendees here.

If you have any questions, please refer to our FAQ section or contact CRISPRMED25 staff at info@crisprmedicineconference.com.

**CRISPRMED25 Newsletter - Sign up here**

See the detailed confirmed speaker list here.

Sponsors and Supporters

  • Ampliqon
  • Aldevron
  • AstraZeneca
  • ChemoMetec
  • Countagen
  • IDT
  • Mission Bio
  • Frontiers
  • Vivlion

Keynote Speaker

  • Virginijus Šikšnys PhD

    Virginijus Šikšnys PhD

    Vilnius University Life Sciences Centre, Lithuania

    Virginijus Šikšnys studied chemistry at Vilnius University and obtained his Ph.D. from Moscow State University before returning to Vilnius where he moved through different research ranks at the Institute of Applied Enzymology/ Institute of Biotechnology. In 1994 he stayed as a visiting scientist in the lab of Prof. Robert Huber at Max Planck Institute of Biochemistry in Germany. Since 2002 he holds the position of Professor of Vilnius University and is the Chief scientist at the Institute of Biotechnology. Currently he holds a chair of distinguished professor at Vilnius University and serves as chairman of the board of Life Science Center of Vilnius University. His research on the CRISPR-Cas has had a major impact on the field. His studies of the Cas9 protein paved the way for development of novel tools for genome editing applications. He is a member of Academia Europaea, EMBO, Lithuania Academy of Sciences and Norwegian Academy of Sciences and Letters. His work has been recently recognised with numerous awards and prizes including the Kavli Prize.

Confirmed Speakers

  • Annarita Miccio

    Annarita Miccio

    Imagine Institut, INSERM UMR1163, Paris Cite' University, France

  • Gerald Schwank

    Gerald Schwank

    University of Zurich, Switzerland

  • Guillermo Montoya

    Guillermo Montoya

    University of Copenhagen, Denmark

  • Jacob Corn

    Jacob Corn

    ETH Zürich

  • Jacob Giehm Mikkelsen

    Jacob Giehm Mikkelsen

    Aarhus University, Denmark

  • Julian Grünewald

    Julian Grünewald

    Technical University of Munich, Germany

  • Kiana Aran

    Kiana Aran

    University of California San Diego, United States

  • Matthew Porteus

    Matthew Porteus

    Stanford University, United States

  • Raffaella Di Micco

    Raffaella Di Micco

    SR-TIGET, Milan and IUSS, Pavia, Italy

  • Suk See De Ravin

    Suk See De Ravin

    National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), United States

  • William H. Peranteau

    William H. Peranteau

    University of Pennsylvania/Children’s Hospital of Philadelphia

  • Alessia Cavazza

    Alessia Cavazza

    University College London, United Kingdom

  • Anna Cereseto

    Anna Cereseto

    University of Trento, Italy

  • Ayal Hendal

    Ayal Hendal

    Bar-Ilan University, Israel

  • Marcello Maresca

    Marcello Maresca

    AstraZeneca AB, Sweden

  • Rasmus O. Bak

    Rasmus O. Bak

    Aarhus University, Denmark

  • Speaker name to be announced

    Speaker name to be announced

    Life Edit Therapeutics

  • Michael Jackson

    Michael Jackson

    Venture Capitalist

Scientific Committee

  • Alessia Cavazza, Ass. Prof., Group Leader, University College London's Great Ormond Street Institute of Child Health, England
  • Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
  • Rasmus O. Bak, Tenured Associate Professor at the Department of Biomedicine at Aarhus University, Co-founder of UNIKUM Therapeutics, Denmark
  • Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
  • Ayal Hendel, Principal Investigator at The Mina and Everard Goodman Faculty of Life Sciences at Bar-Ilan University, Israel
  • Karen O´Hanlon Cohrt, Chief Editor CRISPR Medicine News, CMN

Organising Committee

  • Karen O´Hanlon Cohrt, Chief Editor, CRISPR Medicine News
  • Gorm Palmgren, Science Writer and Editor, CRISPR Medicine News
  • Antonio Carusillo, Science Writer, CRISPR Medicine News
  • Manel Lladó, Science Writer, CRISPR Medicine News
  • Jens-Ole Bock, Founder, CRISPR Medicine News


Copenhagen, Denmark

Registration period

June 30, 2024 - 12:00 AM until April 4, 2025 - 11:59 PM

Submission period

June 30, 2024 - 12:00 AM until January 17, 2025 - 11:59 PM

Contact us

If you have any questions, please contact info@crisprmedicineconference.com .